The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity

NCT00530101 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Doxorubicin

Sponsor

University of Miami

Collaborators

[object Object]